PSYD_2101: TOYAMA

  • Daiki Sasabayashi (Contributor)
  • Ryo Yoshimura (Contributor)
  • Tsutomu Takahashi (Contributor)
  • Yoichiro Takayanagi (Contributor)
  • Shimako Nishiyama (Contributor)
  • Yuko Higuchi (Contributor)
  • Yuko Mizukami (Contributor)
  • Atsushi Furuichi (University of Toyama) (Contributor)
  • Mikio Kido (Contributor)
  • Mihoko Nakamura (Contributor)
  • Kyo Noguchi (Contributor)
  • Michio Suzuki (University of Toyama) (Contributor)

Dataset

Description

This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.Title: A Cross-Sectional Study of Schizophrenia and Clinical High-Risk ParticipantsContributors and PI’s: Tsutomu Takahashi, Daiki SasabayashiDepartment of Neuropsychiatry, University of Toyama, JapanDetails & VariablesAge Range13-52Number of Participants215Diagnostic CriteriaSCZ, CHRNumber of Clinical SubjectsCHR (51), SZ (77)Number of Clinical Subjects (follow-up)N/ANumber of Control Subjects87Number of Control Subjects (follow-up)N/ADemographic InformationAge, Sex, Ethnicity, Height, Handedness, Education, SES, Parental SESClinical MeasurePANSS, CAARMS, BACSCognitive MeasuresIQ, Working Memory, Executive Function, Episodic MemoryFunctioning MeasuresGAFAntipsychotic Medication Information RecordedYesAntipsychotic Medication Name/ Antipsychotic Type Antipsychotic Dose RecordedN/ACPZ Equivalents RecordedN/AOther Medication Variables RecordedNoRecreational Drug/ Alcohol UseYes
Date made available2025
PublisherKing's College London

Cite this